Showing results (471-480 of 700) with videos related to
Sort By:
Pageof 70
Diabetes, Obesity & Metabolism|October 4, 2022
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist usePeter Rossing, Rajiv Agarwal, Stefan D Anker, et al.Journal of the American Heart Association|July 19, 2021
Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE TrialMikkel Jürgens, Morten Schou, Philip Hasbak, et al.Cardiovascular Diabetology|April 8, 2018
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuriaGemma E Currie, Bernt Johan von Scholten, Sheon Mary, et al.Kidney International|May 26, 2026
The Kidney in the Middle: KDIGO Guidelines Address Multiple Key Components of Cardiovascular-Kidney-Metabolic SyndromeAdeera Levin, Nisha Bansal, Ian H de Boer, et al.The International Journal of Cardiovascular Imaging|October 20, 2021
Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trialMads Ersbøll, Mikkel Jürgens, Philip Hasbak, et al.Frontiers in Endocrinology|December 19, 2022
Multiomics signatures of type 1 diabetes with and without albuminuriaMarc Clos-Garcia, Tarunveer S Ahluwalia, Signe A Winther, et al.Diabetologia|October 16, 2020
The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trialKristine Færch, Martin B Blond, Lea Bruhn, et al.Plos One|March 3, 2021
Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuriaSigne Abitz Winther, Jens Christian Øllgaard, Tine Willum Hansen, et al.Diabetes Care|April 13, 2018
Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and MicroalbuminuriaDaniel G K Rasmussen, Tine W Hansen, Bernt J von Scholten, et al.BMJ Open|November 30, 2019
Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)Mikkel Jürgens, Morten Schou, Philip Hasbak, et al.Pageof 70